• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化感染预防与控制:干预措施的系统评价。

Infection prevention and control in cystic fibrosis: a systematic review of interventions.

机构信息

a Evidence Based Child Health Group, Division of Child Health , Obstetrics & Gynaecology, Queens Medical Centre , Nottingham , UK.

出版信息

Expert Rev Respir Med. 2019 May;13(5):425-434. doi: 10.1080/17476348.2019.1595594. Epub 2019 Mar 26.

DOI:10.1080/17476348.2019.1595594
PMID:30892097
Abstract

Cystic fibrosis is a life-limiting genetic condition characterized by recurrent pulmonary infection. Acquisition of infection can occur from environmental reservoirs, person-to-person transmission and from the healthcare environment. Primary prevention of infections through infection prevention and control measures is an important strategy in cystic fibrosis care. Areas covered: Here we present a systematic review of the evidence base around infection prevention and control in cystic fibrosis. We found 36 studies and 7 guidelines that met our inclusion criteria. Strategies covered include cohort segregation, individual segregation, hand hygiene, facemasks, combination strategies, equipment strategies, and adherence. Quality of evidence overall was deemed low or very low. Most guideline recommendations have little or no evidence to support them. Expert opinion: Although low quality, there is an abundance of evidence suggesting segregation is beneficial in reducing pathogen spread. Undertaking high-quality studies may, therefore, be ethically challenging. Large-scale registry studies may provide a better strategy for answering questions on the efficacy of infection control policy. With the rise of antibiotic resistance, effective eradication of cystic fibrosis pathogens is becoming more difficult so primary prevention through infection control will become increasingly important over the coming years.

摘要

囊性纤维化是一种具有生命限制的遗传疾病,其特征是反复发生肺部感染。感染的获得可能来自环境储层、人际传播和医疗保健环境。通过感染预防和控制措施进行感染的初级预防是囊性纤维化护理的重要策略。

涵盖领域

在这里,我们对囊性纤维化感染预防和控制的证据基础进行了系统回顾。我们发现了 36 项研究和 7 项符合纳入标准的指南。涵盖的策略包括队列隔离、个体隔离、手卫生、口罩、联合策略、设备策略和依从性。总体证据质量被认为是低或极低。大多数指南建议几乎没有或没有证据支持。

专家意见

尽管质量较低,但有大量证据表明隔离有助于减少病原体的传播。因此,进行高质量的研究可能在伦理上具有挑战性。大规模登记研究可能为回答有关感染控制政策效果的问题提供更好的策略。随着抗生素耐药性的出现,有效根除囊性纤维化病原体变得越来越困难,因此在未来几年,通过感染控制进行初级预防将变得越来越重要。

相似文献

1
Infection prevention and control in cystic fibrosis: a systematic review of interventions.囊性纤维化感染预防与控制:干预措施的系统评价。
Expert Rev Respir Med. 2019 May;13(5):425-434. doi: 10.1080/17476348.2019.1595594. Epub 2019 Mar 26.
2
Infection prevention and control in cystic fibrosis: An update of a systematic review of interventions.囊性纤维化的感染预防与控制:干预措施系统评价的更新
J Cyst Fibros. 2025 Mar;24(2):359-363. doi: 10.1016/j.jcf.2024.08.004. Epub 2024 Aug 28.
3
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5.
4
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2014 Nov 10(11):CD004197. doi: 10.1002/14651858.CD004197.pub4.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review.囊性纤维化中预防呼吸道病原体感染的隔离措施:一项系统综述
J Hosp Infect. 2006 Sep;64(1):1-6. doi: 10.1016/j.jhin.2006.02.021. Epub 2006 Jul 10.
7
[Cystic fibrosis: physiotherapy and the risk of cross infection].[囊性纤维化:物理治疗与交叉感染风险]
Rev Mal Respir. 2006 Dec;23(6):599-606. doi: 10.1016/s0761-8425(06)72075-7.
8
Nebulised anti-pseudomonal antibiotics for cystic fibrosis.用于囊性纤维化的雾化抗假单胞菌抗生素
Cochrane Database Syst Rev. 2000(2):CD001021. doi: 10.1002/14651858.CD001021.
9
Duration of intravenous antibiotic therapy in people with cystic fibrosis.囊性纤维化患者静脉用抗生素治疗的疗程
Cochrane Database Syst Rev. 2019 Sep 5;9(9):CD006682. doi: 10.1002/14651858.CD006682.pub6.
10
Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张症的感染预防和慢性病管理。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620905272. doi: 10.1177/1753466620905272.

引用本文的文献

1
Drug hypersensitivity reactions in children in clinical practice: A WAO Statement.临床实践中儿童药物过敏反应:世界过敏组织声明
World Allergy Organ J. 2025 Aug 29;18(9):101087. doi: 10.1016/j.waojou.2025.101087. eCollection 2025 Sep.
2
Telerehabilitation in Children and Adolescents with Cystic Fibrosis: A Scoping Review.患有囊性纤维化的儿童和青少年的远程康复:一项范围综述。
Healthcare (Basel). 2024 May 8;12(10):971. doi: 10.3390/healthcare12100971.
3
Hope in Every Breath: Navigating the Therapeutic Landscape of Cystic Fibrosis.
每一次呼吸中的希望:探索囊性纤维化的治疗前景
Cureus. 2023 Aug 16;15(8):e43603. doi: 10.7759/cureus.43603. eCollection 2023 Aug.
4
α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration.α-生育酚在囊性纤维化成人患者中的药代动力学:补充维生素 C 的益处。
Nutrients. 2022 Sep 9;14(18):3717. doi: 10.3390/nu14183717.
5
International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives.与ERN-LUNG PCD核心网络及患者代表合作制定的原发性纤毛运动障碍感染预防与控制的国际BEAT-PCD共识声明。
ERJ Open Res. 2021 Aug 2;7(3). doi: 10.1183/23120541.00301-2021. eCollection 2021 Jul.
6
Infection prevention and control in cystic fibrosis: One size fits all?囊性纤维化的感染预防与控制:一刀切可行吗?
Paediatr Respir Rev. 2020 Nov;36:92-93. doi: 10.1016/j.prrv.2020.06.011. Epub 2020 Jun 20.
7
The future of cystic fibrosis care: a global perspective.囊性纤维化护理的未来:全球视角。
Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27.
8
Adapting the James Lind Alliance priority setting process to better support patient participation: an example from cystic fibrosis.调整詹姆斯·林德联盟的优先事项设定流程以更好地支持患者参与:来自囊性纤维化的一个例子。
Res Involv Engagem. 2019 Aug 20;5:24. doi: 10.1186/s40900-019-0159-x. eCollection 2019.